We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Although the FDA has shifted away from active Part 11 enforcement, agency officials remain committed to ensuring regulated firms demonstrate their computer software does what it is supposed to do, according to experts.